Anti-NGF antibodies and methods using same
First Claim
Patent Images
1. An isolated antibody or fragment thereof comprisinga heavy chain variable region comprising:
- (a) the CDR1 region as shown in SEQ ID NO;
3, or the Kabat or the Chothia CDR thereof,(b) the CDR2 region as shown in SEQ ID NO;
4, or the Chothia CDR thereof, and(c) the CDR3 region as shown in SEQ ID NO;
5, and2) a light chain variable region comprising;
(a) the CDR1 region as shown in SEQ ID NO;
6,(b) the CDR2 region as shown in SEQ ID NO;
7, and(c) the CDR3 region as shown in SEQ ID NO;
8,wherein the antibody or fragment thereof binds human NGF.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.
125 Citations
11 Claims
-
1. An isolated antibody or fragment thereof comprisinga heavy chain variable region comprising:
-
(a) the CDR1 region as shown in SEQ ID NO;
3, or the Kabat or the Chothia CDR thereof,(b) the CDR2 region as shown in SEQ ID NO;
4, or the Chothia CDR thereof, and(c) the CDR3 region as shown in SEQ ID NO;
5, and2) a light chain variable region comprising; (a) the CDR1 region as shown in SEQ ID NO;
6,(b) the CDR2 region as shown in SEQ ID NO;
7, and(c) the CDR3 region as shown in SEQ ID NO;
8,wherein the antibody or fragment thereof binds human NGF. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
Specification